(2Z)-2-[1-hydroxy-methylidene]-4,4-dimethyl-cyclohexanone | 64230-02-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 乙烯基酸
• 英文名称: (2Z)-2-[1-hydroxy-methylidene]-4,4-dimethyl-cyclohexanone
• 英文别名: 2-[1-hydroxy-meth-(Z)-ylidene]-4,4-dimethyl-cyclohexanone；4,4-dimethyl-2-(hydroxymethylene)cyclohexanone；4,4-dimethyl-6-(hydroxymethylene)cyclohexanone；2-hydroxymethylene-4,4-dimethylcyclohexanone；(2Z)-2-(hydroxymethylidene)-4,4-dimethylcyclohexan-1-one
• CAS: 64230-02-0
• 化学式: C₉H₁₄O₂
• 分子量: 154.209
• InChiKey: VWHVRYQCJCNZFJ-SREVYHEPSA-N

物化性质

• 沸点：
  36 °C(Press: 0.05 Torr)
• 密度：
  1.104±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (2Z)-2-[1-hydroxy-methylidene]-4,4-dimethyl-cyclohexanone 在 palladium on activated charcoal platinum(IV) oxide 、 氢气 、 sodium hydride 、 对甲苯磺酸 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 吡啶 、 乙酸乙酯 为溶剂， 反应 20.66h， 生成 4,4-dimethyl-2,3,4a,5,6,7,8,8a-octahydro-1H-naphthalene-1,6-diol
  参考文献：
  名称：

  Annulation of .alpha.-formyl .alpha.,.beta.-unsaturated ketones by a Michael addition-cyclization sequence. A versatile synthesis of alicyclic six-membered rings

  摘要：

  DOI：

  10.1021/jo00204a003
• 作为产物：
  描述：

  4,4-二甲基-2-环己基-1-酮 在 palladium on activated charcoal potassium tert-butylate 、 氢气 作用下， 以 叔丁醇 、 正戊烷 为溶剂， 反应 8.0h， 生成 (2Z)-2-[1-hydroxy-methylidene]-4,4-dimethyl-cyclohexanone
  参考文献：
  名称：

  Annulation of .alpha.-formyl .alpha.,.beta.-unsaturated ketones by a Michael addition-cyclization sequence. A versatile synthesis of alicyclic six-membered rings

  摘要：

  DOI：

  10.1021/jo00204a003

文献信息

• [EN] HEPATITIS C INHIBITOR COMPOUNDS<br/>[FR] COMPOSÉS INHIBITEURS DE L'HÉPATITE C
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2013026163A1

  公开（公告）日：2013-02-28

  A compound of formula (I) useful for the treatment or prevention of hepatitis C viral infection, (Formula (I)) wherein: X1 and X2 are each independently CRB or N; RB is H, (C1-6)alkyl, (C1-6)haloalkyl, halo. -O-(C1-6)alkyl, NH2, NH(C1-6)alkyl or N((C1-6)alkyl)2; R1 and R2 are each independently (C1-6)alkyl optionally mono- or di-substituted with -O-(C1-6)alkyl, NH2, NH(C1-6)alkyl or N((C1-6)alkyl)2; or R1 and R2, together with the carbon to which they are attached, are linked to form a (C3-7)cycloalkyl group or a 3- to 7-membered heterocyclyl, said cycloalkyl and heterocyclyl being optionally mono- or di-substituted with -(C1-6)alkyl; RA is -C(=O)N(R3)(R4), -C(=O)O(R4), heterocyclyl or heteroaryl, wherein each said heterocyclyl and heteroaryl is optionally substituted 1 to 3 times with R41; R5 and R6 are each independently H or (C1-6)alkyl optionally mono- or di-substituted with -O-(C1-6)alkyl, NH2, NH(C1-6)alkyl or N((C1-6)alkyl)2; or R5 and R6, together with the carbon to which they are attached, are linked to form a (C3-7)cycloalkyl group or a 3- to 7-membered heterocyclyl, said cycloalkyl and heterocyclyl being optionally mono- or di-substituted with -(C1-6)alkyl; and n is 0, 1 or 2.

  一种化合物，其化学式为（I），用于治疗或预防丙型肝炎病毒感染，其中：X1和X2分别独立地为CRB或N；RB为H，（C1-6）烷基，（C1-6）卤代烷基，卤基，-O-（C1-6）烷基，NH2，NH（C1-6）烷基或N（（C1-6）烷基）2；R1和R2分别独立地为（C1-6）烷基，可选择地单取代或双取代为-O-（C1-6）烷基，NH2，NH（C1-6）烷基或N（（C1-6）烷基）2；或者R1和R2与它们连接的碳原子一起形成（C3-7）环烷基或3-至7-成员杂环烷基，所述环烷基和杂环烷基可选择地单取代或双取代为-（C1-6）烷基；RA为-C（=O）N（R3）（R4），-C（=O）O（R4），杂环烷基或杂芳基，其中每个所述杂环烷基和杂芳基可选择地用R41取代1至3次；R5和R6分别独立地为H或（C1-6）烷基，可选择地单取代或双取代为-O-（C1-6）烷基，NH2，NH（C1-6）烷基或N（（C1-6）烷基）2；或者R5和R6与它们连接的碳原子一起形成（C3-7）环烷基或3-至7-成员杂环烷基，所述环烷基和杂环烷基可选择地单取代或双取代为-（C1-6）烷基；n为0、1或2。
• [EN] PYRROLOPYRAZINE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE PYRROLOPYRAZINE KINASE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2013030138A1

  公开（公告）日：2013-03-07

  The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.

  本发明涉及式I的新型吡咯并吡嗪衍生物的使用，其中变量如本文所述定义，其抑制JAK和SYK，并可用于治疗自身免疫和炎症性疾病。
• [EN] THERAPEUTIC COMPOUNDS AND METHODS TO TREAT INFECTION<br/>[FR] COMPOSÉS THÉRAPEUTIQUES ET MÉTHODES POUR TRAITER UNE INFECTION
  申请人：UNIV RUTGERS

  公开号：WO2019005841A1

  公开（公告）日：2019-01-03

  Disclosed herein are compounds of formula I: or a salt thereof and compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods for treating or preventing a bacterial infection in an animal comprising administering to the animal a compound of formula I or a pharmaceutically acceptable salt thereof, alone or in combination with a bacterial efflux pump inhibitor.

  本文披露了以下式I的化合物：或其盐，以及包含式I的化合物或其药用可接受的盐的组合物。本文还披露了一种治疗或预防动物细菌感染的方法，包括向动物投与式I的化合物或其药用可接受的盐，单独或与细菌外流泵抑制剂结合。
• Processes To Make Apoptosis Promoters
  申请人：Franczyk, II Thaddeus Stephan

  公开号：US20090318689A1

  公开（公告）日：2009-12-24

  Processes to make compounds, including N-acylsulfonamide apoptosis promoters are disclosed.

  揭示了制备化合物的过程，包括N-酰基磺酰胺凋亡促进剂。
• MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF
  申请人：Honda Tadashi

  公开号：US20110196007A1

  公开（公告）日：2011-08-11

  The present invention features monocyclic cyanoenone compositions and methods for using the same in the treatment of diseases such as cancer, inflammatory diseases and neurodegenerative diseases.

  本发明涉及单环氰基烯酮组合物及其在治疗癌症、炎症性疾病和神经退行性疾病等疾病中的应用方法。